These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 24094719)

  • 41. [Use of anticoagulants and antifibrinolytic agents in the complex treatment of patients with acute pneumonia].
    Sheleg VA
    Vrach Delo; 1985 Feb; (2):110-2. PubMed ID: 3992976
    [No Abstract]   [Full Text] [Related]  

  • 42. Continuous or discontinuous tranexamic acid effectively inhibits fibrinolysis in children undergoing cardiac surgery with cardiopulmonary bypass.
    Couturier R; Rubatti M; Credico C; Louvain-Quintard V; Anerkian V; Doubine S; Vasse M; Grassin-Delyle S
    Blood Coagul Fibrinolysis; 2014 Apr; 25(3):259-65. PubMed ID: 24418941
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Postoperative bleeding after coronary revascularization. Comparison between tranexamic acid and epsilon-aminocaproic acid.
    Maineri P; Covaia G; Realini M; Caccia G; Ucussich E; Luraschi M; Crosta A; Foresti B; Chiaranda M
    Minerva Cardioangiol; 2000 Jun; 48(6):155-60. PubMed ID: 11048468
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tranexamic acid use during coronary artery bypass grafting.
    Rubens F; Wells P
    Ann Thorac Surg; 1996 Feb; 61(2):774-5. PubMed ID: 8572821
    [No Abstract]   [Full Text] [Related]  

  • 45. A prospective randomized controlled study of oral tranexamic acid for preventing postinflammatory hyperpigmentation after Q-switched ruby laser.
    Kato H; Araki J; Eto H; Doi K; Hirai R; Kuno S; Higashino T; Yoshimura K
    Dermatol Surg; 2011 May; 37(5):605-10. PubMed ID: 21457392
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Re-evaluation of the role of antifibrinolytic therapy with lysine analogs during cardiac surgery in the post aprotinin era.
    Koster A; Schirmer U
    Curr Opin Anaesthesiol; 2011 Feb; 24(1):92-7. PubMed ID: 20881484
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antifibrinolytic therapy with tranexamic acid in pregnancy and postpartum.
    Peitsidis P; Kadir RA
    Expert Opin Pharmacother; 2011 Mar; 12(4):503-16. PubMed ID: 21294602
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Natural and synthetic antifibrinolytics: inert, poisonous or therapeutic agents?
    Hardy JF; Bélisle S
    Can J Anaesth; 1997 Sep; 44(9):913-7. PubMed ID: 9305552
    [No Abstract]   [Full Text] [Related]  

  • 49. Use of topical tranexamic acid or aminocaproic acid to prevent bleeding after major surgical procedures.
    Ipema HJ; Tanzi MG
    Ann Pharmacother; 2012 Jan; 46(1):97-107. PubMed ID: 22202494
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Re: Webster K, Wilde J. Management of anticoagulation in patients with prosthetic heart valves undergoing oral and maxillofacial operations. Br J Oral Maxillofac Surg 2000; 38: 124-126.
    Muthukrishnan A
    Br J Oral Maxillofac Surg; 2002 Jun; 40(3):266. PubMed ID: 12054729
    [No Abstract]   [Full Text] [Related]  

  • 51. [Blood loss during total knee-joint replacement: a combination of anticoagulant and hemostatic techniques].
    Kaplunov OA; Mikhin IV; Biriukov SN
    Khirurgiia (Mosk); 2014; (12):41-5. PubMed ID: 25589317
    [No Abstract]   [Full Text] [Related]  

  • 52. Opening an occluded subclavian vein with a screw-like flexible hollow guide-wire and venoplasty.
    Worley SJ; Gohn DC; Pulliam RW
    Pacing Clin Electrophysiol; 2007 Oct; 30(10):1290-3. PubMed ID: 17897137
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tranexamic acid as a means of reducing the need for blood and blood component therapy in children undergoing open heart surgery for congenital cyanotic heart disease.
    Vacharaksa K; Prakanrattana U; Suksompong S; Chumpathong S
    J Med Assoc Thai; 2002 Sep; 85 Suppl 3():S904-9. PubMed ID: 12452228
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tranexamic acid as adjunct therapy to bypassing agents in haemophilia A patients with inhibitors.
    Tran HT; Sørensen B; Rea CJ; Bjørnsen S; Ueland T; Pripp AH; Tjønnfjord GE; Holme PA
    Haemophilia; 2014 May; 20(3):369-75. PubMed ID: 24251535
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Protocol for adapting treatment with vitamin K antagonists before dental extraction].
    Garcia-Darennes F; Darennes J; Freidel M; Breton P
    Rev Stomatol Chir Maxillofac; 2003 Apr; 104(2):69-72. PubMed ID: 12750622
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antifibrinolytics in women with menorrhagia.
    Philipp CS
    Thromb Res; 2011 Feb; 127 Suppl 3():S113-5. PubMed ID: 21262428
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of tranexamic acid vs. aprotinin on blood loss and transfusion requirements after cardiopulmonary bypass: a prospective, randomised, double-blind trial.
    Hekmat K; Zimmermann T; Kampe S; Kasper SM; Weber HJ; Geissler HJ; Mehlhorn U
    Curr Med Res Opin; 2004 Jan; 20(1):121-6. PubMed ID: 14741082
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tranexamic acid (Lysteda) for treatment of menorrhagia.
    Med Lett Drugs Ther; 2010 Jul; 52(1342):54-5. PubMed ID: 20622806
    [No Abstract]   [Full Text] [Related]  

  • 59. Tranexamic acid reduces blood loss and transfusion in reoperative cardiac surgery.
    Dryden PJ; O'Connor JP; Jamieson WR; Reid I; Ansley D; Sadeghi H; Burr LH; Munro AI; Merrick PM
    Can J Anaesth; 1997 Sep; 44(9):934-41. PubMed ID: 9305556
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Predicting results of fibrinogen and platelet levels by TEG6s during cardiopulmonary bypass: A pilot study.
    Tamura T
    J Clin Anesth; 2019 Dec; 58():59-60. PubMed ID: 31078915
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.